National Cancer Institute; Notice of Closed Meetings, 50065-50066 [2013-19903]
Download as PDF
Federal Register / Vol. 78, No. 159 / Friday, August 16, 2013 / Notices
Center for Cancer Research, 9000 Rockville
Pike, Building 31, Room B2B37, MSC 2590,
Bethesda, MD 20892–8349, (301) 451–9399,
sandlera@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/pcp/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 8, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–19902 Filed 8–15–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
emcdonald on DSK67QTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SPORE
REVIEW.
Date: October 1–2, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott Hotel, 5151 Pooks
Hill Road, Bethesda, MD 20812.
Contact Person: Wlodek Lopaczynski, MD,
Ph.D., Scientific Review Officer, Research
Programs Review Branch, Division of
VerDate Mar<15>2010
19:06 Aug 15, 2013
Jkt 229001
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
7W608, Bethesda, MD 20892, 240–276–6458,
lopacw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus Cancer Biology 3.
Date: October 3–4, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Rockville Hotel, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Shakeel Ahmad, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W122,
Bethesda, MD 20892–8328, 240–276–6349,
ahmads@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Drug
Development and Discovery.
Date: October 16–17, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Dr. Room 7W120,
Bethesda, MD 20892, 240–276–6457, mh101v
@nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Utilizing
the PLCO Biospecimens Resource to Bridge
Gaps in Cancer Etiology and Early Detection.
Date: October 16, 2013.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, West Tower, 9609 Medical Center
Drive, Room 1W030, Rockville, MD 20850
(Telephone Conference Call).
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Administrator, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W266, Bethesda, MD 20892–9750,
240–276–6385, lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Research
Answers to NCI’s Provocative Questions—
Group A.
Date: October 17–18, 2013.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Sonya Roberson, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W116, Bethesda, MD 20892, 240–
276–6347, robersos@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Awards for
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
50065
Research on Imaging and Biomarkers for
Early Cancer Detection (U01).
Date: October 21, 2013.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, West Tower, 9609 Medical Center
Drive, Room 3W034, Rockville, MD 20850
(Telephone Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W244,
Bethesda, MD 20892–8329, 240–276–6373,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
J—Career Development.
Date: October 24–25, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, West Tower, 9609 Medical Center
Drive, Room 7W032—24th & 7W30–25th,
Rockville, MD 20850 (Telephone Conference
Call).
Contact Person: Ilda F.S. Melo, Ph.D.,
Scientific Review Officer, Research Training
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, 7W640,
Bethesda, MD 20892, 240–276–6468,
mckennai@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Core
Infrastructure and Methodological Research
for Cancer Epidemiology Cohorts.
Date: October 25, 2013.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, West Tower, 9609 Medical Center
Drive, Room 2W904, Rockville, MD 20850
(Telephone Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W244,
Bethesda, MD 20892–8329, 240–276–6373,
bielatk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus
R03/R21: Tumor Immunology.
Date: November 6–7, 2013.
Time: 6:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Robert Bird, Ph.D., Chief,
Resources and Training Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Bethesda, MD 20892–
8328, 240–276–6344, birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI Small
Grants Program (Omnibus).
Date: November 7, 2013.
Time: 12:00 p.m. to 5:00 p.m.
E:\FR\FM\16AUN1.SGM
16AUN1
50066
Federal Register / Vol. 78, No. 159 / Friday, August 16, 2013 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, West Tower, 9609 Medical Center
Drive, Room 7W034, Rockville, MD 20850
(Telephone Conference Call).
Contact Person: Viatcheslav A.
Soldatenkov, MD, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Bethesda, MD 20892–
8329, 240–276–6378, soldatenkovv@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Therapy.
Date: December 3, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, West Tower, 9609 Medical Center
Drive, Room 7W034, Rockville, MD 20850
(Telephone Conference Call).
Contact Person: Ilda F. S. Melo, Ph.D.,
Scientific Review Officer, Research Training
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, 7W640,
Bethesda, MD 20892, 240–276–6468,
mckennai@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://dea
info.nci.nih.gov/advisory/sep/sep.htm, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: August 8, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–19903 Filed 8–15–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
emcdonald on DSK67QTVN1PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
VerDate Mar<15>2010
19:06 Aug 15, 2013
Jkt 229001
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Child Psychopathology.
Date: September 11, 2013.
Time: 9:00 a.m. to 11:59 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Stacey FitzSimmons,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, 301–451–
9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Psychosocial Risk and Disease Prevention
Study Section.
Date: September 16–17, 2013.
Time: 8:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
Contact Person: Stacey FitzSimmons,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3114,
MSC 7808, Bethesda, MD 20892, 301–451–
9956, fitzsimmonss@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Translational Research in Pediatric and
Obstetric Pharmacology (PAR11–246/248).
Date: September 17, 2013.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Michael Knecht, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6176,
MSC 7892, Bethesda, MD 20892, (301) 435–
1046, knechtm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Members
Conflicts: Biomaterials, Nanotechnology,
Drug Screening and Delivery, Bioengineering
Sciences.
Date: September 17, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ping Fan, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5154,
MSC 7840, Bethesda, MD 20892, 301–408–
9971, fanp@csr.nih.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Myalgic
Encephalomyelitis/Chronic Fatigue
Syndrome.
Date: September 17, 2013.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Lynn E Luethke, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5166,
MSC 7844, Bethesda, MD 20892, (301) 806–
3323, luethkel@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
conflict: Drugs and Alcohol.
Date: September 18–19, 2013.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5164,
MSC 7844, Bethesda, MD 20892, 301–435–
1119, selmanom@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Genes,
Genomes, Genetics Member SEP.
Date: September 19, 2013.
Time: 3:45 p.m. to 4:45 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Michael M. Sveda, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2204,
MSC 7890, Bethesda, MD 20892, 301–435–
3565, svedam@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 12, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–19895 Filed 8–15–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental and
Craniofacial Research; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
E:\FR\FM\16AUN1.SGM
16AUN1
Agencies
[Federal Register Volume 78, Number 159 (Friday, August 16, 2013)]
[Notices]
[Pages 50065-50066]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-19903]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SPORE REVIEW.
Date: October 1-2, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda Marriott Hotel, 5151 Pooks Hill Road, Bethesda,
MD 20812.
Contact Person: Wlodek Lopaczynski, MD, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, 7W608, Bethesda, MD 20892, 240-276-6458, lopacw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus Cancer Biology 3.
Date: October 3-4, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Rockville Hotel, 1750 Rockville Pike, Rockville,
MD 20852.
Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W122, Bethesda, MD 20892-8328, 240-276-6349, ahmads@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Drug Development and Discovery.
Date: October 16-17, 2013.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Majed M. Hamawy, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center Dr.
Room 7W120, Bethesda, MD 20892, 240-276-6457, mh101v@nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Utilizing the PLCO Biospecimens Resource to Bridge Gaps in
Cancer Etiology and Early Detection.
Date: October 16, 2013.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, West Tower, 9609
Medical Center Drive, Room 1W030, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W266, Bethesda, MD 20892-9750, 240-276-6385,
lovingeg@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Research Answers to NCI's Provocative Questions--Group A.
Date: October 17-18, 2013.
Time: 4:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Sonya Roberson, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W116, Bethesda, MD 20892, 240-276-6347,
robersos@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Awards for Research on Imaging and Biomarkers for Early
Cancer Detection (U01).
Date: October 21, 2013.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, West Tower, 9609
Medical Center Drive, Room 3W034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W244, Bethesda, MD 20892-8329, 240-276-6373,
bielatk@mail.nih.gov.
Name of Committee: National Cancer Institute Initial Review
Group; Subcommittee J--Career Development.
Date: October 24-25, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, West Tower, 9609
Medical Center Drive, Room 7W032--24th & 7W30-25th, Rockville, MD
20850 (Telephone Conference Call).
Contact Person: Ilda F.S. Melo, Ph.D., Scientific Review
Officer, Research Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, 7W640, Bethesda, MD 20892, 240-276-6468,
mckennai@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Core Infrastructure and Methodological Research for Cancer
Epidemiology Cohorts.
Date: October 25, 2013.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, West Tower, 9609
Medical Center Drive, Room 2W904, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Kenneth L. Bielat, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W244, Bethesda, MD 20892-8329, 240-276-6373,
bielatk@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus R03/R21: Tumor Immunology.
Date: November 6-7, 2013.
Time: 6:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Robert Bird, Ph.D., Chief, Resources and
Training Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110,
Bethesda, MD 20892-8328, 240-276-6344, birdr@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Small Grants Program (Omnibus).
Date: November 7, 2013.
Time: 12:00 p.m. to 5:00 p.m.
[[Page 50066]]
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, West Tower, 9609
Medical Center Drive, Room 7W034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Viatcheslav A. Soldatenkov, MD, Ph.D.,
Scientific Review Officer, Special Review and Logistics Branch,
Division of Extramural Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-
276-6378, soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Therapy.
Date: December 3, 2013.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, West Tower, 9609
Medical Center Drive, Room 7W034, Rockville, MD 20850 (Telephone
Conference Call).
Contact Person: Ilda F. S. Melo, Ph.D., Scientific Review
Officer, Research Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, 7W640, Bethesda, MD 20892, 240-276-6468,
mckennai@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: August 8, 2013.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-19903 Filed 8-15-13; 8:45 am]
BILLING CODE 4140-01-P